Literature DB >> 8934051

Spermatocytic seminoma: a clinicopathological review of ten patients.

S Pendlebury1, A Horwich, D P Dearnaley, J Nicholls, C Fisher.   

Abstract

Spermatocytic seminoma is an uncommon variety of testicular neoplasm, differing from its classical counterpart at both clinical and pathological levels and having a low propensity to metastasize. This is a retrospective review of ten patients with pathologically confirmed and reviewed disease who were seen at the Royal Marsden Hospital. All patients presented as Stage I. Five were treated with radiotherapy and five have undergone surveillance. The median age was 56.5 years. The median follow-up is 8 years and no patient has relapsed. Two have died of intercurrent disease. Our series supports others of a similar size in the literature with respect to both the rarity and the good prognosis of spermatocytic seminoma. With only one case of relapse confirmed in the literature, this is a subgroup of patients in whom radiotherapy can safely be omitted.

Entities:  

Mesh:

Year:  1996        PMID: 8934051     DOI: 10.1016/s0936-6555(05)80719-8

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  4 in total

1.  Metastatic prostatic carcinoma to testis: histological features mimicking lymphoma.

Authors:  Bisong Haupt; Jae Y Ro; Alberto G Ayala; Jim Zhai
Journal:  Int J Clin Exp Pathol       Date:  2008-05-10

2.  Spermatocytic seminoma at the National Institute of Oncology in Morocco.

Authors:  Ghizlane G Raiss; Marwane M Benatiya Andaloussi; Soundouss S Raissouni; Hind H Mrabti; Hassan H Errihani
Journal:  BMC Res Notes       Date:  2011-06-29

3.  Bilateral spermatocytic seminoma: a case report.

Authors:  Hadley Narins; Kent Chevli; Richard Gilbert; Michael Duff; Andrew Toenniessen; Yan Hu
Journal:  Res Rep Urol       Date:  2014-06-12

Review 4.  Predicting Gonadal Germ Cell Cancer in People with Disorders of Sex Development; Insights from Developmental Biology.

Authors:  Leendert H J Looijenga; Chia-Sui Kao; Muhammad T Idrees
Journal:  Int J Mol Sci       Date:  2019-10-10       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.